Gambia vs Sur: Previously treated cases tested for RR-/MDR-TB
Gambia
100.0%
in 2024
Sur
62.0%
in 2024
Gambia rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Gambia
- Sur
How they compare
Gambia currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Gambia's figure about 1.6 times Sur's.
The two have swapped places 6 times across 14 shared years of data; in 2008 it was Gambia ahead.
Gambia ranks 1st and Sur ranks 2nd of 180 countries.
Across the 3 decades both report, Gambia averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Gambia | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 21.5% | 28.5% | Gambia |
| 2010s | 53.6% | 55.4% | 1.9% | Sur |
| 2020s | 89.4% | 78.4% | 11.0% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Sur?
- Gambia, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Sur?
- 38.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Sur?
- 14 years are reported by both, from 2008 to 2024.
- How do Gambia and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.